{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:29:29Z","timestamp":1794536969978,"version":"4.9.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016114","name":"Zhejiang Medical Association","doi-asserted-by":"publisher","award":["2023ZYC-Z01"],"award-info":[{"award-number":["2023ZYC-Z01"]}],"id":[{"id":"10.13039\/501100016114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015258","name":"Zhejiang Provincial People's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2021KY472"],"award-info":[{"award-number":["2021KY472"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.diabres.2025.112384","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T22:35:38Z","timestamp":1753569338000},"page":"112384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A review of the relationship between epicardial adipose tissue and cerebral white matter microstructural damage in type 2 diabetes mellitus"],"prefix":"10.1016","volume":"227","author":[{"given":"Zhicheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingzhou","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.112384_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.diabres.2025.112384_b0010","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2025.112384_b0015","article-title":"Altered white matter microstructures in type 2 diabetes mellitus: a coordinate-based meta-analysis of diffusion tensor imaging studies","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.diabres.2025.112384_b0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/svn-2023-002791","article-title":"White matter disease derived from vascular and demyelinating origins","volume":"9","author":"Zhang","year":"2024","journal-title":"Stroke Vasc Neurol"},{"issue":"4","key":"10.1016\/j.diabres.2025.112384_b0025","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jnnp-2017-316603","article-title":"CSF \u03b2-amyloid and white matter damage: a new perspective on Alzheimer's disease","volume":"89","author":"Pietroboni","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.diabres.2025.112384_b0030","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/STROKEAHA.124.045903","article-title":"WMH contributions to cognitive impairment: rationale and design of the diverse VCID study","volume":"56","author":"Decarli","year":"2025","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0035","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/STROKEAHA.124.047910","article-title":"Heterogeneity and penumbra of white matter hyperintensities in small vessel diseases determined by quantitative MRI","volume":"56","author":"Voorter","year":"2025","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1148\/radiol.2371041496","article-title":"Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people","volume":"237","author":"Murray","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.diabres.2025.112384_b0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2019.07.016","article-title":"Abdominal fatness and cerebral white matter hyperintensity","volume":"404","author":"Nam","year":"2019","journal-title":"J Neurol Sci"},{"issue":"9","key":"10.1016\/j.diabres.2025.112384_b0050","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"10.1016\/j.diabres.2025.112384_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092275","article-title":"The adipose organ is a unitary structure in mice and humans","volume":"10","author":"Giordano","year":"2022","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.diabres.2025.112384_b0060","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.tem.2011.07.003","article-title":"Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features","volume":"22","author":"Iacobellis","year":"2011","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.diabres.2025.112384_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/biom14111465","article-title":"Cardio-lipotoxicity of epicardial adipose tissue","volume":"14","author":"Bodenstab","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0070","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40200-023-01195-4","article-title":"Potential impact of epicardial fat thickness, pentraxin-3, and high-sensitive C-reactive protein on the risk of non-proliferative diabetic retinopathy","volume":"22","author":"Gameil","year":"2023","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0075","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12933-024-02411-y","article-title":"Fully automated epicardial adipose tissue volume quantification with deep learning and relationship with CAC score and micro\/macrovascular complications in people living with type 2 diabetes: the multicenter EPIDIAB study","volume":"23","author":"Gaborit","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.diabres.2025.112384_b0080","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4093\/dmj.2015.39.5.405","article-title":"Increased epicardial adipose tissue thickness in type 2 diabetes mellitus and obesity","volume":"39","author":"Song","year":"2015","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.diabres.2025.112384_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.583175","article-title":"Emerging role of adipocyte dysfunction in inducing heart failure among obese patients with prediabetes and known diabetes mellitus","volume":"7","author":"Berezin","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.diabres.2025.112384_b0090","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2020-0441","article-title":"FABP4 and omentin-1 gene expression in epicardial adipose tissue from coronary artery disease patients","volume":"44","author":"Miroshnikova","year":"2021","journal-title":"Genet Mol Biol"},{"issue":"4","key":"10.1016\/j.diabres.2025.112384_b0095","first-page":"430","article-title":"Epicardial adipose tissue assessment and current status of clinical application in children","volume":"51","author":"Shiganmo","year":"2023","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2265.2011.04140.x","article-title":"Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue","volume":"76","author":"Salgado-Somoza","year":"2012","journal-title":"Clin Endocrinol"},{"issue":"9","key":"10.1016\/j.diabres.2025.112384_b0105","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41419-021-04111-x","article-title":"Secretory products from epicardial adipose tissue induce adverse myocardial remodeling after myocardial infarction by promoting reactive oxygen species accumulation","volume":"12","author":"Hao","year":"2021","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0110","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2011.10.026","article-title":"Expression of fat mobilizing genes in human epicardial adipose tissue","volume":"220","author":"Jaffer","year":"2012","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.diabres.2025.112384_b0115","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1365-2265.2008.03411.x","article-title":"Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis","volume":"70","author":"Wang","year":"2009","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12933-021-01420-5","article-title":"Epicardial adipose tissue volume and myocardial ischemia in asymptomatic people living with diabetes: a cross-sectional study","volume":"20","author":"Cosson","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.diabres.2025.112384_b0125","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5603\/KP.a2016.0167","article-title":"The relationship between location-specific epicardial adipose tissue volume and coronary atherosclerotic plaque burden in type 2 diabetic patients","volume":"75","author":"Uygur","year":"2017","journal-title":"Kardiol Pol"},{"issue":"4","key":"10.1016\/j.diabres.2025.112384_b0130","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/1479164119827602","article-title":"Echocardiographic association of epicardial fat with carotid intima-media thickness in patients with type 2 diabetes","volume":"16","author":"Yafei","year":"2019","journal-title":"Diab Vasc Dis Res"},{"issue":"7","key":"10.1016\/j.diabres.2025.112384_b0135","first-page":"1794","article-title":"Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy","volume":"7","author":"Akbas","year":"2014","journal-title":"Int J Clin Exp Med"},{"issue":"8","key":"10.1016\/j.diabres.2025.112384_b0140","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s40618-019-1011-8","article-title":"Epicardial adipose tissue is a predictor of decreased kidney function and coronary artery calcification in youth- and early adult onset type 2 diabetes mellitus","volume":"42","author":"Reinhardt","year":"2019","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"10.1016\/j.diabres.2025.112384_b0145","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","article-title":"Diabetic cardiomyopathy","volume":"124","author":"Dillmann","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2025.112384_b0150","doi-asserted-by":"crossref","DOI":"10.1177\/10742484231151820","article-title":"Epicardial adipose tissue and diabetic cardiomyopathy","volume":"28","author":"Yang","year":"2023","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/dom.14861","article-title":"Epicardial adipose tissue thickness is associated with reduced peak oxygen consumption and systolic reserve in patients with type 2 diabetes and normal heart function","volume":"25","author":"Nesti","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2025.112384_b0160","article-title":"Epicardial adipose tissue is associated with geometry alteration and diastolic dysfunction in prediabetic cardiomyopathy","author":"Hsu","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.diabres.2025.112384_b0165","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1007\/s40519-022-01420-8","article-title":"The density of crown-like structures in epicardial adipose tissue could play a role in cardiovascular diseases","volume":"27","author":"Malavazos","year":"2022","journal-title":"Eat Weight Disord"},{"issue":"6","key":"10.1016\/j.diabres.2025.112384_b0170","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/oby.22798","article-title":"Effects of dapagliflozin on epicardial fat thickness in patients with type 2 diabetes and obesity","volume":"28","author":"Iacobellis","year":"2020","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12933-023-02091-0","article-title":"Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes","volume":"22","author":"Cinti","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12933-021-01237-2","article-title":"Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study","volume":"20","author":"Gaborit","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"10.1016\/j.diabres.2025.112384_b0185","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jchf.2021.04.014","article-title":"Mechanistic insights of empagliflozin in nondiabetic patients with HFrEF: from the EMPA-TROPISM study","volume":"9","author":"Requena-Ib\u00e1\u00f1ez","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0190","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12933-017-0658-8","article-title":"The effect of dapagliflozin treatment on epicardial adipose tissue volume","volume":"17","author":"Sato","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2025.112384_b0195","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13098-017-0275-4","article-title":"Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus","volume":"9","author":"Yagi","year":"2017","journal-title":"Diabetol Metab Syndr"},{"issue":"6","key":"10.1016\/j.diabres.2025.112384_b0200","doi-asserted-by":"crossref","first-page":"724","DOI":"10.4239\/wjd.v14.i6.724","article-title":"Targeting epicardial adipose tissue: a potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus","volume":"14","author":"Shi","year":"2023","journal-title":"World J Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0205","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/CIRCULATIONAHA.112.127514","article-title":"Protein kinase C-\u03b2 contributes to impaired endothelial insulin signaling in humans with diabetes mellitus","volume":"127","author":"Tabit","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2025.112384_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110103","article-title":"Angiogenesis in obesity","volume":"126","author":"Nijhawans","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"10.1016\/j.diabres.2025.112384_b0215","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1113\/JP282728","article-title":"Regulation of cardiovascular health and disease by visceral adipose tissue-derived metabolic hormones","volume":"601","author":"Vasamsetti","year":"2023","journal-title":"J Physiol"},{"issue":"5","key":"10.1016\/j.diabres.2025.112384_b0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052973","article-title":"New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications","volume":"25","author":"Gallo","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.diabres.2025.112384_b0225","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000518221","article-title":"Endostatin in renal and cardiovascular diseases","volume":"7","author":"Li","year":"2021","journal-title":"Kidney Dis (Basel)"},{"issue":"4","key":"10.1016\/j.diabres.2025.112384_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044004","article-title":"Fibrosis: types, effects, markers, mechanisms for disease progression, and its relation with oxidative stress, immunity, and inflammation","volume":"24","author":"Antar","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.diabres.2025.112384_b0235","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1006\/jmcc.1995.0044","article-title":"Modulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 on human coronary smooth muscle cells by cytokines","volume":"27","author":"Braun","year":"1995","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"10.1016\/j.diabres.2025.112384_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10082054","article-title":"Production of reactive oxygen species by epicardial adipocytes is associated with an increase in postprandial glycemia, postprandial insulin, and a decrease in serum adiponectin in patients with severe coronary atherosclerosis","volume":"10","author":"Naryzhnaya","year":"2022","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.diabres.2025.112384_b0245","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11883-017-0678-6","article-title":"Oxidative stress in atherosclerosis","volume":"19","author":"Kattoor","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.diabres.2025.112384_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.868958","article-title":"Cholesterol and HIF-1\u03b1: dangerous liaisons in atherosclerosis","volume":"13","author":"Thomas","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.diabres.2025.112384_b0255","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/ajh\/hpx032","article-title":"Hemodynamic consequences of changes in microvascular structure","volume":"30","author":"Rizzoni","year":"2017","journal-title":"Am J Hypertens"},{"issue":"15","key":"10.1016\/j.diabres.2025.112384_b0260","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029415","article-title":"Epicardial adipose tissue-derived leptin promotes myocardial injury in metabolic syndrome rats through PKC\/NADPH oxidase\/ROS pathway","volume":"12","author":"Chen","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"16","key":"10.1016\/j.diabres.2025.112384_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612912","article-title":"Alterations of oligodendrocyte and myelin energy metabolism in multiple sclerosis","volume":"24","author":"L\u00f3pez-Muguruza","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.diabres.2025.112384_b0270","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/bpa.12571","article-title":"Oxidative stress and mitochondrial dynamics malfunction are linked in Pelizaeus-Merzbacher disease","volume":"28","author":"Ruiz","year":"2018","journal-title":"Brain Pathol"},{"issue":"2","key":"10.1016\/j.diabres.2025.112384_b0275","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s11033-021-06208-0","article-title":"Imbalance in thioredoxin system activates NLRP3 inflammasome pathway in epicardial adipose tissue of patients with coronary artery disease","volume":"48","author":"Shateri","year":"2021","journal-title":"Mol Biol Rep"},{"issue":"3","key":"10.1016\/j.diabres.2025.112384_b0280","doi-asserted-by":"crossref","DOI":"10.1177\/0300060521997590","article-title":"Role of TLR4\/MyD88\/NF-\u03baB signaling in heart and liver-related complications in a rat model of type 2 diabetes mellitus","volume":"49","author":"Tian","year":"2021","journal-title":"J Int Med Res"},{"issue":"8","key":"10.1016\/j.diabres.2025.112384_b0285","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1007\/s11064-023-03923-x","article-title":"Ischemia reperfusion injury induced blood brain barrier dysfunction and the involved molecular mechanism","volume":"48","author":"Guo","year":"2023","journal-title":"Neurochem Res"},{"key":"10.1016\/j.diabres.2025.112384_b0290","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.2147\/JIR.S350109","article-title":"Microglia-mediated neuroinflammation: a potential target for the treatment of cardiovascular diseases","volume":"15","author":"Wang","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.diabres.2025.112384_b0295","doi-asserted-by":"crossref","DOI":"10.1007\/s13760-024-02706-7","article-title":"Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer's disease","author":"Ahlawat","year":"2025","journal-title":"Acta Neurol Belg"},{"issue":"11","key":"10.1016\/j.diabres.2025.112384_b0300","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s00018-005-5597-y","article-title":"Glycogen synthase kinase 3beta and Alzheimer's disease: pathophysiological and therapeutic significance","volume":"63","author":"Balaraman","year":"2006","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"10.1016\/j.diabres.2025.112384_b0305","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.diabres.2025.112384_b0310","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2147\/DMSO.S182406","article-title":"Leptin resistance: underlying mechanisms and diagnosis","volume":"12","author":"Gruzdeva","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0315","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1152\/ajpendo.90744.2008","article-title":"Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation","volume":"297","author":"J\u00f8rgensen","year":"2009","journal-title":"Am J Phys Endocrinol Metab"},{"key":"10.1016\/j.diabres.2025.112384_b0320","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4021623","article-title":"Visfatin induces inflammation and insulin resistance via the NF-\u03baB and STAT3 signaling pathways in hepatocytes","volume":"2019","author":"Heo","year":"2019","journal-title":"J Diabetes Res"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0325","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/s41598-025-85812-7","article-title":"Association of homocysteine and uric acid with type 2 diabetes mellitus: a case-control study","volume":"15","author":"Yang","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2025.112384_b0330","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.883845","article-title":"The association of homocysteine and diabetic retinopathy in homocysteine cycle in Chinese patients with type 2 diabetes","volume":"13","author":"Luo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0335","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12882-022-03045-6","article-title":"Relationship between plasma homocysteine and chronic kidney disease in US patients with type 2 diabetes mellitus: a cross-sectional study","volume":"23","author":"Shen","year":"2022","journal-title":"BMC Nephrol"},{"issue":"20","key":"10.1016\/j.diabres.2025.112384_b0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207698","article-title":"Homocysteine and mitochondria in cardiovascular and cerebrovascular systems","volume":"21","author":"Kaplan","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2025.112384_b0345","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fnut.2019.00049","article-title":"Hyperhomocysteinemia as a risk factor and potential nutraceutical target for certain pathologies","volume":"6","author":"Tinelli","year":"2019","journal-title":"Front Nutr"},{"key":"10.1016\/j.diabres.2025.112384_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111260","article-title":"Homocysteine decreases VEGF, EGF, and TrkB levels and increases CCL5\/RANTES in the hippocampus: neuroprotective effects of rivastigmine and ibuprofen","volume":"403","author":"Ramires J\u00fanior","year":"2024","journal-title":"Chem Biol Interact"},{"issue":"9","key":"10.1016\/j.diabres.2025.112384_b0355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094843","article-title":"Reticulum (ER) stress and its role in pancreatic \u03b2-cell dysfunction and senescence in type 2 diabetes","volume":"23","author":"Lee","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6 Pt A","key":"10.1016\/j.diabres.2025.112384_b0360","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.bbadis.2018.03.025","article-title":"Proteostasis in epicardial versus subcutaneous adipose tissue in heart failure subjects with and without diabetes","volume":"1864","author":"Burgeiro","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0365","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12916-024-03479-9","article-title":"Associations of serum uric acid variability with neuroimaging metrics and cognitive decline: a population-based cohort study","volume":"22","author":"Lv","year":"2024","journal-title":"BMC Med"},{"issue":"16","key":"10.1016\/j.diabres.2025.112384_b0370","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/1381612827666210104124320","article-title":"Serum uric acid and diabetes: from pathophysiology to cardiovascular disease","volume":"27","author":"Katsiki","year":"2021","journal-title":"Curr Pharm Des"},{"issue":"7","key":"10.1016\/j.diabres.2025.112384_b0375","first-page":"e153","article-title":"Serum uric acid in relation with the metabolic syndrome components and adiponectin levels in Lebanese University students","volume":"34","author":"Chedid","year":"2011","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.diabres.2025.112384_b0380","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063188","article-title":"Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment","volume":"23","author":"Gherghina","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.diabres.2025.112384_b0385","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","article-title":"Hyperuricemia and its related diseases: mechanisms and advances in therapy","volume":"9","author":"Du","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.diabres.2025.112384_b0390","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jpsychires.2021.10.039","article-title":"Epicardial adipose tissue and adrenal gland volume in patients with borderline personality disorder","volume":"144","author":"Richter","year":"2021","journal-title":"J Psychiatr Res"},{"issue":"11","key":"10.1016\/j.diabres.2025.112384_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105203","article-title":"Epicardial adipose thickness and neutrophil lymphocyte ratio in acute occlusive cerebrovascular diseases","volume":"29","author":"Yildiz","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.diabres.2025.112384_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.110102","article-title":"Epicardial and periaortic fat characteristics in ischemic stroke: relationship with stroke etiology and calcification burden","volume":"146","author":"Rodr\u00edguez-Granillo","year":"2022","journal-title":"Eur J Radiol"},{"issue":"7","key":"10.1016\/j.diabres.2025.112384_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102562","article-title":"Effect of glucagon-like peptide-1 (GLP-1) analogues on epicardial adipose tissue: a meta-analysis","volume":"16","author":"Berg","year":"2022","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"10.1016\/j.diabres.2025.112384_b0410","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/dom.16107","article-title":"SGLT2 inhibitors reduce epicardial adipose tissue more than GLP-1 agonists or exercise interventions in patients with type 2 diabetes mellitus and\/or obesity: a systematic review and network meta-analysis","volume":"27","author":"Bao","year":"2025","journal-title":"Diabetes Obes Metab"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725003985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725003985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T21:25:39Z","timestamp":1756934739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725003985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":82,"alternative-id":["S0168822725003985"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112384","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of the relationship between epicardial adipose tissue and cerebral white matter microstructural damage in type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112384"}}